A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
Recruiting · NCT05389293 · Registry updated 2026-08-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-08-10 | NCT05389293 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 753 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Georgetown University (Data Collection Only) | Washington D.C. | United States | 1 |
| Hackensack Meridian Health (Data Collection Only) | Hackensack | United States | 6 |
| Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities | Basking Ridge | United States | 3 |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale | United States | 184 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Middletown | United States | 186 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Rockville Centre | United States | 35 |
| Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) | Commack | United States | 19 |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison | United States | 166 |